RadNet's DeepHealth receives FDA 510(k) clearance for AI-powered chest X-ray abnormality detection.
Key Details
- 1DeepHealth, a RadNet subsidiary, gained FDA 510(k) clearance for its Chest XRay AI tool.
- 2The solution uses a foundation model trained on large datasets of chest radiographs.
- 3It is designed to detect and localize suspected thoracic abnormalities on chest X-rays.
- 4The model is already in use in Europe via a CE-marked version, analyzing over 2.8 million exams yearly.
- 5The platform is intended to support current detection and enable future workflow tools.
Why It Matters
FDA clearance of foundation model-based AI signals growing regulatory acceptance and clinical adoption of advanced imaging AI solutions, positioning the tool as a scalable platform for further workflow enhancements in radiology.
Source
Radiology Business
Related News
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
Healthcare Leader Warns AI Will Dominate Diagnostic Radiology
A leading oncologist urges future radiologists to specialize in interventional procedures due to AI advances in image interpretation.
•Radiology Business
Harrison.ai Restructures and Launches U.S. AI-Enabled Teleradiology Venture
Harrison.ai lays off staff amid major restructuring and launches Frontier Radiology, an AI-powered U.S. teleradiology business.